NutraLife BioSciences (NLBS) 10-Q/A 19 Nov 14 2014 Q3 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014
Document and Entity Information:	'
Entity Registrant Name	'NUTRAFUELS INC
Document Type	'10-Q
Document Period End Date	30-Sep-14
Amendment Flag	'false
Entity Central Index Key	'0001563463
Current Fiscal Year End Date	'--12-31
Entity Common Stock, Shares Outstanding	21,788,408
Entity Filer Category	'Smaller Reporting Company
Entity Current Reporting Status	'Yes
Entity Voluntary Filers	'No
Entity Well-known Seasoned Issuer	'No
Document Fiscal Year Focus	'2014
Document Fiscal Period Focus	'Q3

NutraFuels_Inc_Balance_Sheets

NutraFuels, Inc. - Balance Sheets (USD $)	Sep. 30, 2014		Dec. 31, 2013
Current Assets:	'		'
Cash	$27,055		$63,255
Accounts receivable	12,503		10,068
Subscription receivable	'		25,000
Inventory	274,115		274,925
TOTAL CURRENT ASSETS	313,673		373,247
Property, Plant and Equipment, net	262,098	[1]	274,282	[1]
Total Assets	575,771		647,529
Current Liabilities:	'		'
Accounts payable	26,754		109,707
Accrued liabilities	103,886		41,099
Convertible debt	437,650	[2]	262,823	[2]
Convertible debt, related party	210,000		210,000
Notes payable	25,000		'
Notes payable, related party	95,000		95,000
Total Current Liabilities	898,290		718,629
Stockholders' Deficit	'		'
Preferred stock	'	[3]	'	[3]
Common stock	2,200	[4]	2,124	[4]
Additional paid-in capital	3,773,385		2,707,549
Retained earnings	-4,098,104		-2,780,773
SHAREHOLDERS' DEFICIT	-322,519		-71,100
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$575,771		$647,529
[1]	net of accumulated depreciation of $85,399 and $46,092, respectively.
[2]	net of discount of $282,350 and $87,177
[3]	$0.0001 par value; Authorized 10,000; issued and outstanding 1,000 and 10,000 respectively.
[4]	$0.0001 par value; Authorized 500,000,000; issued and outstanding 21,998,408 and 21,238,408 respectively.

Statement_of_Financial_Positio

Statement of Financial Position - Parenthetical (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position	'	'
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000	10,000
Preferred Stock, Shares Issued	1,000	1,000
Preferred Stock, Shares Outstanding	1,000	1,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	21,998,408	21,238,408
Common Stock, Shares Outstanding	21,998,408	21,238,408

NutraFuels_Inc_Statements_of_O

NutraFuels, Inc. - Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement	'	'	'	'
Revenue	$5,337	$192,243	$53,247	$479,328
Cost of revenues	88,332	90,058	144,098	183,305
Gross profit (loss)	-82,995	102,185	-90,851	296,023
Operating Expenses:	'	'	'	'
Advertising and promotion	72,612	54,484	253,859	168,519
Administrative salaries	48,500	59,221	132,500	125,289
Selling, general, and administrative	180,022	571,429	542,144	1,547,065
Depreciation	13,135	12,438	39,307	38,772
TOTAL OPERATING EXPENSES	314,269	697,572	977,810	1,879,645
Other Income (Expense):	'	'	'	'
Income for Indebtedness	'	'	7,956	'
Interest Income	1	'	15	'
Interest Expense	-102,621	-7,239	-256,641	-34,461
Net Loss	($499,884)	($602,626)	($1,317,331)	($1,618,083)
Net loss per common share- basic and diluted	($0.02)	($0.03)	($0.06)	($0.09)
Weighted average common shares outstanding- basic and diluted	21,857,865	20,971,595	21,593,151	17,526,309

NutraFuels_Inc_Statements_of_C

NutraFuels, Inc. - Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating Activities:	'	'
Net Loss	($1,317,331)	($1,618,083)
Adjustments to reconcile net loss to net cash used in operations:	'	'
Depreciation	39,307	38,772
Stock for services- related party	'	896,313
Stock for services	29,314	381,247
Amortization of Debt Discount	191,427	9,317
Reclassification of Down Payment for Equipment	-22,400	'
Income from Indebtedness	-7,956	'
Changes in operating assets and liabilities:	'	'
Accounts receivable, increase decrease	-2,435	-84,610
Subscription receivable, increase decrease	25,000	'
Inventory, increase decrease	810	-241,630
Accrued expenses, increase decrease	62,787	25,243
Accounts payable, increase decrease	-74,999	-50,956
Net Cash Used In Operating Activities	-1,076,476	-644,387
Investing Activities:	'	'
Purchase of fixed assets	-4,724	-263,810
Net cash used in Investing Activities	-4,724	-263,810
Financing Activities:	'	'
Common stock issued for cash	650,000	390,000
Borrowings on debt	420,000	300,000
Repayments on debt, related party	'	-310,600
Repayments on debt	-25,000	'
Borrowings on debt, related party	'	455,000
Net Cash Provided by Financing Activities	1,045,000	834,400
Net decrease for the period	-36,200	-73,797
Cash, beginning of period	63,255	144,750
Cash, end of period	27,055	70,953
Supplementary Cash Flow Information:	'	'
Interest paid in cash	'	'
Income tax paid in cash	'	'
Non-cash financing and investing activities:	'	'
Shares issued for conversion of debt	'	150,000
Debt discount from beneficial conversion feature	43,822	'
Shares issued with the issuance of debt	52,778	111,803
Warrants issued with the issuance of debt	$290,000	'

Note_1_Description_of_Business

Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies	'
	NOTE 1 – DESCRIPTION OF BUSINESS, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Description of Business
	Nutrafuels is the producer of nutritional supplements that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption.
	Basis of presentation
	The financial statements have been prepared by Nutrafuels, Inc. in accordance with accounting principles generally accepted in the United States.  The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the financial position and operating results for the respective periods.
	Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Company’s most recent annual report on Form 10-K, have been omitted.

Note_2_Going_Concern

Note 2 - Going Concern	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 2 - Going Concern	'
	NOTE 2 – GOING CONCERN
	As shown in the accompanying financial statements, we have incurred losses from inception, including net losses of $1,317,331 for the nine months ended September 30, 2014.  In response to these conditions, we may raise additional capital through the sale of equity securities, through an offering of debt securities or through borrowings from financial institutions or individuals.  The financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

Note_3_notes_Payable

Note 3 -notes Payable	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 3 -notes Payable	'
	NOTE 3 – NOTES PAYABLE
	During February 2014, an investor loaned the Company $50,000 with a maturity date of May 1, 2014.  The investor also received 50,000 shares of common stock in conjunction with the loan.  The proceeds were allocated using relative fair value to the stock and loan as follows:
	Relative fair value of stock	$	25,000
	Relative fair value of note payable	$	25,000
	The discount on the note, $25,000, will be recognized as additional interest over the life of the note.  As of September 30, 2014, the note’s discount has been fully amortized.
	The note became due on May 1, 2014 and has not been paid in full as of September 30, 2014.  An informal extension has been granted by the investor.[s1]

Note_4_Convertible_Debt

Note 4 - Convertible Debt	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 4 - Convertible Debt	'
	NOTE 4 – CONVERTIBLE DEBT
	On March 26, 2014, the Company borrowed $290,000 under a convertible note agreement with an investor.  The note bears an interest rate of 10%, matures on March 26, 2015, and is convertible at $1.00 per share.  The investor received warrants to purchase 500,000 shares of common stock at $0.50 per share with a two year exercise term.
	We evaluated the warrants for derivative accounting consideration under ASC Topic 815-40, Derivatives and Hedging – Contracts in Entity’s own stock.  We concluded that the warrants meet the criteria for classification in stockholders' equity.  Therefore, derivative accounting is not applicable for the warrants.  Accordingly, we allocated the proceeds from the transaction to the debt, stock, and warrants based on their relative fair value.  We determined the fair value of the warrants using a Black-Sholes option pricing model with the following inputs:
	Risk-free interest rate	0.45	%
	Dividend yield	-	%
	Volatility factor	145	%
	Expected life (years)	2
	The volatility was determined by referring to the average historical volatility of a peer group of public companies because we do not have a trading history from which to determine historical volatility.
	The fair value of the investment was allocated between the note and warrant as follows:
	Relative fair value of warrants	$167,447
	Relative fair value of note payable	$122,553
	Because the price for recent sales of common stock exceeded the effective conversion price, we also recognized a beneficial conversion feature of $122,553.  The total discount on the note, $290,000, will be recognized as additional interest over the life of the note.  As of September 30, 2014, the remaining amount of the discount is $221,346.
	On June 7, 2013, we entered into a convertible note in the principal amount of 100,000 which bears interest at the rate of 10% per annum.  At the option of the investor, the outstanding principal and interest due under the note may be converted into shares of our common stock at the price of $1.00 per share.  The note had originally had a due date of June 1, 2014 and was convertible at the most recent price we offered or sold common in an offering registered with the Securities and Exchange Commission.  On September 7, 2013, the note was amended to allow the amounts outstanding to be converted into our common stock at the price of $1.00 per share.
	The note became due on June 1, 2014 and has not been paid as of September 30, 2014.  Subsequent to September 30, 2014, the note was amended and granted new due date of June 1, 2015.
	On August 26, 2013, we entered into a note agreement with an investor with a principal amount of $200,000.  The note bears interest at the rate of 15% per annum and is due on August 26, 2014.  Under the terms of the note, the investor received 250,000 common shares and 500,000 common stock purchase warrants.  The warrants are exercisable at the price of $0.75 per share at any time prior to August 26, 2015.
	The note became due August 26, 2014 and has not been paid as of September 30, 2014.  Subsequent to September 30, 2014, the note was amended and granted new due date of August 26, 2015.
	On June 23, 2014, the Company borrowed $30,000 under a convertible note agreement with an investor.  The note bears an interest rate of 10%, matures on June 23, 2015, and is convertible at $1.00 per share.  Because the market price for our common stock on the date of the note exceeded the note’s conversion price, $1.00 per share, we recognized a beneficial conversion feature of $21,600 as a discount on the note.  The discount will be recognized as additional interest over the life of the note.  As of September 30, 2014, the remaining amount of the discount is $18,382.
	On August 27, 2014, the Company borrowed $50,000 under a convertible note agreement with an investor.  The note bears an interest rate of 10%, matures on January 2 2015, and is convertible at $1.00 per share.  The investor also received 50,000 shares of common stock with the issuance of the note.
	The fair value of the investment was allocated among the shares, note payable, and beneficial conversion feature:
	Relative fair value of shares	$27,778
	Relative fair value of conversion feature	$22,222
	Relative fair value of note payable	$           -
	The note is fully discounted in the amount of $50,000 will be amortized over the life of the note.  As of September 30, 2014, the remaining balance on the debt discount is $42,622.
	We evaluated the conversion features embedded in the notes payable described above for derivative accounting in accordance with ASC 815-40, Derivatives and Hedging embedded in the modified notes payable for derivative accounting in accordance with the criteria for classification in stockholders' equity.  Therefore, derivative accounting is not applicable.

Note_5_Shareholders_Equity

Note 5 - Shareholders' Equity	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 5 - Shareholders' Equity	'
	NOTE 5 – SHAREHOLDERS’ EQUITY
	During April 2014, an investor purchased 500,000 shares for $1.00 per share.  The investor also received warrants to purchase 500,000 shares at exercise price of $0.50 per share.  The warrants have a one-year term.
	During September 2014, an investor purchased 150,000 shares for $1.00 per share.  The investor also received warrants to purchase 150,000 shares at exercise price of $0.20 per share.  The warrants have a one-year term.
	For the three months ended September 30, 2014, there were 10,000 shares of stock issued for services, resulting in stock based compensation expense of $29,314.

Note_6_Commitments_Contingenci

Note 6 - Commitments & Contingencies	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 6 - Commitments & Contingencies	'
	NOTE 6 – COMMITMENTS & CONTINGENCIES
	During January 2014, we were granted a license to market nutritional supplements under the TapouT XT name to retail locations worldwide.  Under the license agreement, we are required to pay a royalty fee to Nutra Evolution of 12.5% of net sales.  The agreement provides us with an initial test period of four years, until January 31, 2018, to distribute the product.  We paid $85,000 in conjunction with the license.  At the expiration of this four year period, we may extend the license for three (3) consecutive three (3) year terms.  We are required to pay minimum royalties of $400,000 during the first contract year; $750,000 during the second contract year and $1,000,000 each year thereafter.
	In late April 2014, the Company entered into an agreement with Sullivan Media Group, a Nevada corporation, to conduct market research in regards to promotion of the NutraFuels brand at a cost of $104,500.
	On May 26, 2014, we entered into an agreement with SRC Sales Inc., a Massachusetts corporation (“SRC Sales”) to be the exclusive distributor of our products to certain retailers (the “Retailer Accounts”) in the United States and Canada.  We agreed to pay 7% of sales derived from any Retailer Account obtained from the efforts of SRC Sales.  The agreement has a term of 36 months.  We agreed to issue 50,000 restricted shares of our common stock to SRC Sales for each Retailer Account, and 50,000 shares for each order of $500,000.  For purposes of the agreement, Retailer Account means a retailer with more than 200 locations.  The terms of the Agreement do not apply to any of our prior or existing customers.

Note_7_Notes_Payable_Related_P

Note 7 - Notes Payable - Related Party	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 7 - Notes Payable - Related Party	'
	NOTE 7 – NOTES PAYABLE - RELATED PARTY
	As of September 30 2014, the Company is indebted to Neil Catania, vice president, for $305,000.  From time to time, Mr. Catania has advanced funds to the Company with no formal note agreement.  During 2013, Mr. Catania advanced $405,000 to the Company and the Company repaid $310,000, resulting a net balance due to him of $95,000.  The remaining $210,000 relates to two convertible notes payable, which are described below.
	On November 15, 2012, the Company borrowed $135,000 under a convertible note agreement with Neil Catania, vice president.  Under the original terms of the note, it was convertible at the most recent price of shares sold in an offering registered with SEC.  The note bears interest at 10% and is due on November 15, 2014.  As of December 31, 2012, $160,000 in principal was outstanding.  During September 2013, the note was modified to establish a set conversion price of $1.00 per share.  Because no registered offering of our common stock has occurred, the notes did not have an effective conversion feature before the modification occurred and thus derivative treatment could not be determined.  Additionally, there was no beneficial conversion feature associated with the notes prior to their modification.
	Subsequent to September 30, 2014, the note was amended and granted new due date of November 15, 2015.
	We evaluated the modification using the criteria set forth in ASC Topic 470-50, Debt – Modifications and Extinguishments and we determined that the modification was an extinguishment because there was a substantial modification of terms.  However, we did not experience a gain or loss on extinguishment because the fair value of the extinguished note was the same as the fair value of the modified note.  There was no beneficial conversion feature associated with the modified note because the conversion price equaled or exceeded the cash sales prices of common stock ($.35 per share) that had occurred before the modification.
	On February 15, 2013 Mr. Catania lent the Company an additional $50,000.  The note is convertible into common stock at a price of $1.00 per share.  The note bears interest at 10% and is due on May 15, 2014.  The conversion feature was not beneficial at the time of issuance because the conversion price equaled or exceeded the cash sales prices of common stock ($.35 per share) that had occurred before the modification.
	The note became due on May 15, 2014 and has not been paid as of September 30, 2014.  Subsequent to September 30, 2014, the note was amended and granted new due date of November 15, 2015.
	We evaluated the conversion features embedded in the modified November Note and the February Note for derivative accounting in accordance with ASC 815-40, Derivatives and Hedging – Contracts in Entity’s own stock and concluded that the conversion features meet the criteria for classification in stockholders' equity.  Therefore, derivative accounting is not applicable.
	On February 15, 2012, we entered into a convertible note with an investor with an aggregate principal and interest outstanding of $50,000 which bears interest at the rate of 10% per annum.  The note had originally had a due date of November 15, 2013 and was convertible at the most recent price we offered or sold common in an offering registered with the Securities and Exchange Commission.  On September 7, 2013, the note was amended to (i) extend the repayment date to November 15, 2014 and allow the amounts outstanding to be converted into our common stock at the price of $1.00 per share.
	Subsequent to September 30, 2014, the note was amended and granted new due date of January 15, 2015.

Note_8_Subsequent_Events

Note 8 - Subsequent Events	9 Months Ended
	Sep. 30, 2014
Notes	'
Note 8 - Subsequent Events	'
	NOTE 8 – SUBSEQUENT EVENTS
	During October 2014, [s2] the company entered into a convertible note with an investor with a principal amount of $60,000, and bears an interest rate of 10%.  As additional consideration for providing the principal amount, the investor shall also receive 150,000 shares of common stock.
	The note was due on November 2, 2014 and has not been paid.
	In November 2014, the Company issued a $30,000 convertible note along with an equity consideration to raise additional capital.
	During November 2014, the due dates for several notes payable was extended, as detailed in Notes 4 and 7.

Note_1_Description_of_Business1

Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies: Description of Business (Policies)	9 Months Ended
	Sep. 30, 2014
Policies	'
Description of Business	'
	Description of Business
	Nutrafuels is the producer of nutritional supplements that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption.

Note_1_Description_of_Business2

Note 1 - Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2014
Policies	'
Basis of Presentation	'
	Basis of presentation
	The financial statements have been prepared by Nutrafuels, Inc. in accordance with accounting principles generally accepted in the United States.  The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments), which are, in the opinion of management, necessary to fairly present the financial position and operating results for the respective periods.
	Notes to the financial statements which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period, as reported in the Company’s most recent annual report on Form 10-K, have been omitted.

Note_3_notes_Payable_Schedule_

Note 3 -notes Payable: Schedule of Fair Value Stock and Loan (Tables)	9 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Fair Value Stock and Loan	'
	Relative fair value of stock	$	25,000
	Relative fair value of note payable	$	25,000

Note_4_Convertible_Debt_Schedu

Note 4 - Convertible Debt: Schedule of Derivative Liabilities at Fair Value (Tables)	9 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Derivative Liabilities at Fair Value	'
	Risk-free interest rate	0.45	%
	Dividend yield	-	%
	Volatility factor	145	%
	Expected life (years)	2

Note_4_Convertible_Debt_Schedu1

Note 4 - Convertible Debt: Schedule of Fair Value Note and Warrant (Tables)	9 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Fair Value Note and Warrant	'
	Relative fair value of warrants	$167,447
	Relative fair value of note payable	$122,553

Note_4_Convertible_Debt_Schedu2

Note 4 - Convertible Debt: Schedule of Fair Value Investment (Tables)	9 Months Ended
	Sep. 30, 2014
Tables/Schedules	'
Schedule of Fair Value Investment	'
	Relative fair value of shares	$27,778
	Relative fair value of conversion feature	$22,222
	Relative fair value of note payable	$           -

Note_2_Going_Concern_Details

Note 2 - Going Concern (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Details	'	'	'	'
Net Loss	$499,884	$602,626	$1,317,331	$1,618,083

Note_3_notes_Payable_Details

Note 3 -notes Payable (Details) (USD $)	Feb. 28, 2014
Details	'
Loans Payable	$50,000
Shares, Issued	50,000

Note_3_notes_Payable_Schedule_1

Note 3 -notes Payable: Schedule of Fair Value Stock and Loan (Details) (Stock and Loan, USD $)	9 Months Ended
	Sep. 30, 2014
Stock and Loan	'
Relative Fair Value Stock	$25,000
Relative Fair Value Note Payable	$25,000

Note_4_Convertible_Debt_Detail

Note 4 - Convertible Debt (Details) (USD $)	Sep. 30, 2014	Aug. 27, 2014	Jun. 23, 2014	Apr. 30, 2014	Mar. 26, 2014	Dec. 31, 2013	Sep. 07, 2013	Aug. 26, 2013	Jun. 07, 2013	Feb. 15, 2012
Details	'	'	'	'	'	'	'	'	'	'
Subscription receivable	'	'	'	'	$290,000	$25,000	'	'	'	'
Short-term Debt, Percentage Bearing Fixed Interest Rate	'	'	'	'	10.00%	'	'	'	'	'
Debt Conversion Converted Instrument Warrants or Options Issued	150,000	'	'	500,000	500,000	'	'	'	'	'
Common Stock, Par Value	$0.00	$1	$1	$1	$0.50	$0.00	$1	'	$1	'
Beneficial Conversion Feature	122,553	'	21,600	'	'	'	'	'	'	'
Debt Discount	221,346	'	'	'	'	'	'	'	'	'
Convertible Note Issued	'	'	'	'	'	'	'	'	100,000	'
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	'	'	10.00%	'	'	'	'	15.00%	10.00%	10.00%
Notes and Loans Payable	'	'	30,000	'	'	'	'	200,000	'	'
Warrant Exercise Price	'	'	'	'	'	'	'	$0.75	'	'
Debt Instrument, Unamortized Discount	18,382	'	'	'	'	'	'	'	'	'
Discounted Note	'	50,000	'	'	'	'	'	'	'	'
Discounted Note	50,000	'	'	'	'	'	'	'	'	'
Long-term Debt	$42,622	'	'	'	'	'	'	'	'	'

Note_4_Convertible_Debt_Schedu3

Note 4 - Convertible Debt: Schedule of Derivative Liabilities at Fair Value (Details)	3 Months Ended
	Sep. 30, 2014
Details	'
Derivative, Variable Interest Rate	0.45%
Fair Value Assumptions, Expected Volatility Rate	145.00%
Remaining Contractual Term	2

Note_4_Convertible_Debt_Schedu4

Note 4 - Convertible Debt: Schedule of Fair Value Note and Warrant (Details) (Note and Warrants, USD $)	3 Months Ended
	Sep. 30, 2014
Note and Warrants	'
Relative Fair Value Warrants	$167,447
Relative Fair Value Note Payable	$122,553

Note_4_Convertible_Debt_Schedu5

Note 4 - Convertible Debt: Schedule of Fair Value Investment (Details) (USD $)	Sep. 30, 2014
Details	'
Relative Fair Value of Shares	$27,778
Relative Fair Value of Conversion Feature	$22,222

Note_5_Shareholders_Equity_Det

Note 5 - Shareholders' Equity (Details) (USD $)	1 Months Ended		3 Months Ended
	Sep. 30, 2014	Apr. 30, 2014	Sep. 30, 2014	Aug. 27, 2014	Jun. 23, 2014	Mar. 26, 2014	Dec. 31, 2013	Sep. 07, 2013	Jun. 07, 2013
Details	'	'	'	'	'	'	'	'	'
Common Stock Shares Purchased	150,000	500,000	'	'	'	'	'	'	'
Common Stock, Par Value	$0.00	$1	$0.00	$1	$1	$0.50	$0.00	$1	$1
Debt Conversion Converted Instrument Warrants or Options Issued	150,000	500,000	150,000	'	'	500,000	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	$0.20	$0.50	$0.20	'	'	'	'	'	'
Common Stock Price Per Share	$1	'	'	'	'	'	'	'	'
Stock Issued During Period, Shares, Issued for Services	'	'	10,000	'	'	'	'	'	'
Share-based Compensation	'	'	$29,314	'	'	'	'	'	'

Note_6_Commitments_Contingenci1

Note 6 - Commitments & Contingencies (Details) (Sullivan Media Group, USD $)	1 Months Ended
	Apr. 30, 2014	Jan. 31, 2014
Sullivan Media Group	'	'
Proceeds from License Fees Received	'	$85,000
Marketing Expense	$104,500	'

Note_7_Notes_Payable_Related_P1

Note 7 - Notes Payable - Related Party (Details) (USD $)

Sep. 30, 2014

Aug. 27, 2014

Jun. 23, 2014

Apr. 30, 2014

Mar. 26, 2014

Dec. 31, 2013

Sep. 07, 2013

Aug. 26, 2013

Jun. 07, 2013

Feb. 15, 2012

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Feb. 15, 2013

Dec. 31, 2012

Nov. 15, 2012

Feb. 15, 2012

Neil Catania

Neil Catania

Neil Catania

Neil Catania

Neil Catania

Neil Catania

Neil Catania

Due to Related Parties, Current

'

'

'

'

'

'

'

'

'

'

$305,000

$405,000

'

'

'

$135,000

'

Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate

'

'

10.00%

'

'

'

'

15.00%

10.00%

10.00%

'

'

'

'

'

10.00%

'

Debt Instrument Principal Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

160,000

'

'

Debt Instrument Convertible Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

Loans Payable, Current

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

Common Stock, Par Value

$0.00

$1

$1

$1

$0.50

$0.00

$1

'

$1

'

'

'

'

$1

'

'

'

Accounts Payable, Interest-bearing, Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

'

'

Debt Instrument, Debt Default, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$50,000

Sale of Stock, Price Per Share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1